We’ve been working hard, see you in 2019…

Proft J, Rzhepetskyy Y, Lazniewska J, Zhang FX, Cain SM, Snutch TP, Zamponi GW, Weiss N.

The Cacna1h mutation in the GAERS model of abscence epilepsy enhances T-type Ca2+ currents by altering calnexin-dependent trafficking of Cav3.2 channels.

Scientific Reports 2017; (7). doi:10.1038/s41598-017-11591-5

Rivas-Ramirez P, Gadotti VM, Zamponi GW, Weiss N.

Surfen is a broad-spectrum calcium channel inhibitor with analgesic properties in mouse models of acute and chronic inflammatory pain.

Pflugers Arch. 2017; 469:1325-1334. doi: 10.1007/s00424-017-2017-8

Weiss N, Zamponi GW.

Trafficking of neuronal calcium channels.

Neuronal Signaling 2017; 1(1) NS20160003. doi: https://doi.org/10.1042/NS20160003

Lazniewska J, Weiss N.

Glycosylation of voltage-gated calcium channels in health and disease.

Biochim Biophys Acta 2017; 1859(5):662-668. doi: 10.1016/j.bbamem.2017.01.018

Felix R, Weiss N.

Ubiquitination and proteasome-mediated degradation of voltage-gated Ca2+ channels and potential pathophysiological implications.

Gen Physiol Biophys 2017; 36(1):1-5. doi: 10.4149/gpb_2016037

Lacinova L, Weiss N.

It takes two T to shape immunity: emerging role for T-type calcium channels in immune cells.

Gen Physiol Biophys. 2016 Oct;35(4):393-396.

Lazniewska J, Rzhepetskyy Y, Zhang FX, Zamponi GW, Weiss N.

Cooperative roles of glucose and asparagine-linked glycosylation in T-type calcium channel expression.

Pflugers Arch. 2016 Nov;468(11-12):1837-1851.

Rzhepetskyy Y, Lazniewska J, Blesneac I, Pamphlett R, Weiss N.

CACNA1H missense mutations associated with amyotrophic lateral sclerosis alter Cav3.2 T-type calcium channel activity and reticular thalamic neuron firing.

Channels (Austin). 2016 Nov;10(6):466-77.

Lazniewska J, Weiss N.

Glycosylation of α2δ1 subunit: a sweet talk with Cav1.2 channels.

Gen Physiol Biophys. 2016 Jul;35(3):239-42.

Rzhepetskyy Y, Lazniewska J, Proft J, Campiglio M, Flucher B, Weiss N.

A Cav3.2/Stac1 molecular complex controls T-type channel expression at the plasma membrane.

Channels (Austin). 2016 Sep 2;10(5):346-354.

Ondacova K, Karmazinova M, Lazniewska J, Weiss N, Lacinova L.

Modulation of Cav3.2 T-type calcium channel permeability by asparagine-linked glycosylation.

Channels (Austin). 2016;10(3):175-84.

Weiss N, Lacinova L.

T-type channels: release a brake, engage a gear.

Channels (Austin). 2016;10(2):78-80.

Weiss N, De Waard M.

Biophysical methods to analyze direct G-protein regulation of neuronal voltage-gated calcium channels.

Receptors and Ion Channel Detection in the Brain – Methods and Protocols. 2016; 357-368.

Lazniewska J, Weiss N.

The “sweet” side of ion channels.

Rev Physiol Biochem Pharmacol. 2014;167:67-114.

Proft J, Weiss N.

Rectifying rectifier channels in Huntington disease.

Commun Integr Biol. 2014 Jun 13;7:e29410.

García-Caballero A, Gadotti VM, Stemkowski P, Weiss N, Souza IA, Hodgkinson V, Bladen C, Chen L, Hamid J, Pizzoccaro A, Deage M, François A, Bourinet E, Zamponi GW.

The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity.

                          Neuron. 2014 Sep 3;83(5):1144-58.

Proft J, Weiss N.

T-type Ca(2+) channels: New players in the aging brain.

Commun Integr Biol. 2014 Jan 1;7(1):e28424.